Discover 2,355 paid clinical trials in Joliet, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,355
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
for
Mantle Cell Lymphoma
Location: Munster IN, Dyer IN, Chicago IL, Indianapolis IN,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 60+
Code: NCT05976763
Phase3, Recruiting
Trial to Compare the Effects of Myo Munchee Therapy and Oral Motor Therapy (OMT) in Pediatric Patients to Treat Maxillary Deficiency and Orofacial Myofunctional Dysfunction (OMD).
for
Orofacial Myofunctional Disorders, Myo Munchee,
Location: Chicago IL
Sponsor: Myo Munchee (Operations) Pty Ltd
Sex: All
Age: 3 - 5
Code: NCT07088055
Recruiting
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for
Breast Cancer
Location: Dyer IN, Chicago IL, Arlington Heights IL, Milwaukee WI,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06492616
Phase3, Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
for
Triple-Negative Breast Cancer
Location: Dyer IN, Arlington Heights IL, Skokie IL, Madison WI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06393374
Phase3, Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: Dyer IN, Chicago IL, Arlington Heights IL,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Dyer IN, Chicago IL, Urbana IL, Springfield IL,
Sponsor: BriaCell Therapeutics Corporation
Sex: All
Age: 18+
Code: NCT06072612
Phase3, Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for
Acute Coronary Syndrome
Location: Munster IN, Chicago IL, Glenview IL,
Sponsor: DalCor Pharmaceuticals
Sex: All
Age: 45+
Code: NCT05918861
Phase3, Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for
Heart Failure
Location: Munster IN, Chicago IL, Park Ridge IL, Island Lake IL,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT06677060
Phase3, Recruiting
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
for
Refractory Angina
Location: Munster IN, Chicago IL, Milwaukee WI, Madison WI,
Sponsor: Shockwave Medical, Inc.
Sex: All
Age: 18+
Code: NCT05102019
Recruiting
Reducing Overdose and Substance Use-related Stigma by Training Non-substance-using Friends and Family Members of People Who Use Opioids to Be Harm Reduction Champions
for
Opioid Overdose Prevention,
Location: Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 18+
Code: NCT06823453
Recruiting
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
for
Tumor Hyperinsulinism (Tumor HI)
Location: Chicago IL, Rochester MN, Canton OH, Bethesda MD,
Sponsor: Rezolute
Sex: All
Age: 18+
Code: NCT06881992
Phase3, Recruiting
Transdermal Optical Imaging (TOI) as a Non-invasive Measure to Detect Changes in Hydration Status in Healthy Adults and Athletes
for
Dehydration
Location: Chicago IL, Valhalla NY, Plano TX, Bradenton FL
Sponsor: PepsiCo Global R&D
Sex: All
Age: 14 - 65
Code: NCT06212518
Recruiting
Feasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related Outcomes
for
Hydration
Location: Chicago IL
Sponsor: PepsiCo Global R&D
Sex: All
Age: 18 - 65
Code: NCT07005895
Recruiting
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Location: Chicago IL, Grand Rapids MI, Nashville TN,
Sponsor: Context Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06756035
Phase1, Recruiting
First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
for
Solid Tumor, Adult
Location: Chicago IL, Nashville TN, Huntersville NC,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT06554795
Phase1, Phase2, Recruiting
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
for
HIV Infections
Location: Chicago IL, Cincinnati OH, Louisville KY, Columbia MO,
Sponsor: ViiV Healthcare
Sex: All
Age: 18+
Code: NCT07202546
Phase2, Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
for
Gastrointestinal Neoplasms
Location: Chicago IL, Milwaukee WI, Iowa City IA, St Louis MO,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07218926
Phase3, Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
for
Chronic Myeloid Leukemia, CML, CML, Chronic Phase
Location: Chicago IL, Decatur IL, Indianapolis IN, St Louis MO,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT06423911
Phase3, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations